MicroRNAs and Lymph Node Metastatic Disease in Lung Cancer

Thoracic Surgery Clinics

Volumn 22, Issue 2, 2012, Pages 167-175

  Fazi, Francesco ^a   Fontemaggi, Giulia ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Lung cancer; Lymph node metastasis; MicroRNAs

Indexed keywords

MICRORNA;

BIOGENESIS; CANCER GROWTH; GENE EXPRESSION; GENE LOCUS; HUMAN; LUNG CANCER; LYMPH NODE METASTASIS; ONCOGENE; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

DISEASE PROGRESSION; DNA METHYLATION; GENETIC MARKERS; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MICRORNAS; NEOPLASM INVASIVENESS; RNA, NEOPLASM;

EID: 84859966781     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2011.11.001     Document Type: Review

References (62)

1. Pepper M.S. Lymphangiogenesis and tumor metastasis: myth or reality?. Clin Cancer Res 2001, 7:462-468.
2. Shayan R., Achen M.G., Stacker S.A. Lymphatic vessels in cancer metastasis: bridging gaps. Carcinogenesis 2006, 27:1729-1738.
3. Alitalo K., Tammela T., Petrova T.V. Lymphangiogenesis in development and human disease. Nature 2005, 438:946-953.
4. Alitalo K., Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002, 1:219-227.
5. Sahai E., Marshall C.J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signaling and extracellular proteolysis. Nat Cell Biol 2003, 5:711-718.
6. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2:563-572.
7. Luzzi K.J., MacDonald I.C., Schmidt E.E., et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998, 153:865-873.
8. Kumar M.S., Lu J., Mercer K.L., et al. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007, 39:673-677.
9. Egger G., Liang G., Aparicio A., et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004, 429:457-463.
10. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
11. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5(7):522-531.
12. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
13. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
14. Chen C.Z., Li L., Lodish H.F., et al. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
15. Poy M.N., Eliasson L., Krutzfeldt J., et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
16. Yi R., O'Carroll D., Pasolli H.A., et al. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat Genet 2006, 38:356-362.
17. Kosik K.S. The neuronal microRNA system. Nat Rev Neurosci 2006, 7:911-920.
18. Fazi F., Nervi C. MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination. Cardiovasc Res 2008, 79:553-561.
19. Eulalio A., Behm-Ansmant I., Izaurralde E. P bodies: at the crossroads of post-transcriptional pathways. Nat Rev Mol Cell Biol 2007, 8(1):9-22.
20. Mendell J.T. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 2005, 4:1179-1184.
21. He L., Thomson J.M., Hemann M.T., et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435:828-833.
22. Kent O.A., Mendell J.T. A small piece in the cancer puzzle: microRNA as tumor suppressors and oncogene. Oncogene 2006, 25:6188-6196.
23. Hummond S.M. MicroRNA as oncogenes. Curr Opin Genet Dev 2006, 16:4-9.
24. Esequela-Kercher A., Slack F.J. Oncomir-microRNA with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
25. Deng S., Calin G.A., Croce C.M., et al. Mechanisms of microRNA deregulation in human cancer. Cell Cycle 2008, 7(17):2643-2646.
26. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancer. Nature 2005, 435:834-838.
27. Calin G.A., Ferracin M., Cimmino A., et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukaemia. N Engl J Med 2005, 353:1793-1801.
28. Cummins J.M., Velculescu V.E. Implication of microRNA profiling for cancer diagnosis. Oncogene 2006, 25:6220-6227.
29. Cortez M.A., Ivan C., Zhou P., et al. MicroRNAs in cancer: from bench to bedside. Adv Cancer Res 2010, 108:113-157.
30. Takamizawa J., Konishi H., Yanagisawa K., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004, 64(11):3753-3756.
31. Mayr C., Hemann M.T., Bartel D.P. Disrupting the pairing between let-7 and HMGA2 enhances oncogenic transformation. Science 2007, 315:1576-1579.
32. Kumar M.S., Erkeland S.J., Pester R.E., et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A 2008, 105(10):3903-3908.
33. Mendell J.T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133:217-222.
34. Liu X., Sempere L.F., Ouyang H., et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 2010, 120(4):1298-1309.
35. Hatley M.E., Patrick D.M., Garcia M.R., et al. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 2010, 18(3):282-293.
36. Raponi M., Dossey L., Jatkoe T., et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 2009, 69:5776-5783.
37. Yanaihara N., Caplen N., Bowman E., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
38. Park S.M., Gaur A.B., Lengyel E., et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008, 22(7):894-907.
39. Gregory P.A., Bert A.G., Paterson E.L., et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008, 10(5):593-601.
40. Ceppi P., Mudduluru G., Kumarswamy R., et al. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res 2010, 8(9):1207-1216.
41. Sleeman J.P. The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res 2000, 157:55-81.
42. Jackson D.G. Lymphatic markers, tumour lymphangiogenesis and lymph node metastasis. Cancer Treat Res 2007, 135:39-53.
43. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003, 3:453-458.
44. Asamura H., Suzuki K., Kondo H. Where is the boundary between N1 and N2 station in lung cancer?. Ann Thorac Surg 2000, 70:1839-1845.
45. Wu J., Ohta Y., Minato H., et al. Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. Ann Thorac Surg 2001, 71:1772-1778.
46. Pieterman R.M., van Putten J.W., Meuzelaar J.J., et al. Preoperative staging of non-small cell lung cancer with positron-emission tomography. N Engl J Med 2000, 343:254-261.
47. Kernstine K.H., Mclaughlin K.A., Menda Y., et al. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable non-small cell lung cancer?. Ann Thorac Surg 2002, 73:394-402.
48. Nomori H., Watanabe K., Ohtsuka T., et al. The size of metastatic foci and lymph node staging yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer. J Thorac Cardiovasc Surg 2004, 127:1087-1092.
49. Mitchell P.S., Parkin R.K., Kroh E.M., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105(30):10513-10518.
50. Liu X.G., Zhu W.Y., Huang Y.Y., et al. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 2011, [Epub ahead of print].
51. Wang Z.X., Bian H.B., Wang J.R., et al. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. J Surg Oncol 2011, 104(7):847-851.
52. Wang R., Wang Z.X., Yang J.S., et al. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 2011, 30(23):2644-2658.
53. Wang X.C., Tian L.L., Wu H.L., et al. Expression of miRNA-130a in non small cell lung cancer. Am J Med Sci 2010, 340(5):385-388.
54. Jiang L., Huang Q., Zhang S., et al. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer 2010, 10:318.
55. Donnem T., Eklo K., Berg T., et al. Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization. J Transl Med 2011, 9:6.
56. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103(7):2257-2261.
57. Voortman J., Goto A., Mendiboure J., et al. MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res 2010, 70(21):8288-8298.
58. Hu Y., Correa A.M., Hoque A., et al. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 2011, 128:132-143.
59. Saito Y., Liang G., Egger G., et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006, 9(6):435-443.
60. Lujambio A., Calin G.A., Villanueva A., et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 2008, 105(36):13556-13561.
61. Watanabe K., Emoto N., Hamano E., et al. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer. Int J Cancer 2011, [Epub ahead of print].
62. Baffa R., Fassan M., Volinia S., et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 2009, 219(2):214-221.